Feinstein Institute Scientist Recognized for I... - CLL Support

CLL Support

23,087 members39,645 posts

Feinstein Institute Scientist Recognized for Innovative CLL Research

Cllcanada profile image
CllcanadaTop Poster CURE Hero
0 Replies

Feinstein Institute for Medical Research Instructor Shih-Shih Chen, PhD, is continuing the Institute's tradition of innovating the diagnosis and treatment of chronic lymphocytic leukemia (CLL) through the recognition of her research that identifies a potential new therapy target for CLL.

The award was presented at the recent International Workshop on Chronic Lymphocytic Leukemia (iwCLL) for her abstract titled: "IL-4R – IL-4 axis Disruption by Ibrutinib Therapy Contributes to the Greater Vulnerability of U-CLL Clones to Loss of Microenvironmental Input."

These latest findings join the contributions made by Feinstein Institute Professors Kanti R. Rai, MD, and Nicholas Chiorazzi, MD, who have long been at the forefront of diagnosis and care of patients with CLL.

prnewswire.com/news-release...

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

FDA Approves Venetoclax (VENCLEXTA) For CLL or SLL with or without 17p deletion, who have received at least one prior therapy

FDA Approves Venetoclax (VENCLEXTA) For Chronic Lymphocytic Leukemia or Small Lymphocytic...

Advances in Targeted Therapy for R/R CLL OncLive videos & transcripts by Nirav Shah MD & Nicole Lamanna MD

Advances in Targeted Therapy for R/R CLL (These OncLive presentations are intended for medical...

Research survey on CLL/SLL

Hi We are doing some research in follow up to our abstract from ASH 2016 and would appreciate your...

Combination therapy for our CLL

Hi, This week, I am sharing a video of Dr. Jennifer Brown from Dana Farber Cancer Institute where...

MRD assessment in CLL

Nice explanation of MRD testing and it's use for guiding treatment. ASCO 2019 | MRD assessment in...